- Home
- NRIM vs VNDA Comparison
NRIM vs VNDA Comparison
Compare NRIM & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRIM
- VNDA
- Stock Information
- Founded
- NRIM 1990
- VNDA 2002
- Country
- NRIM United States
- VNDA United States
- Employees
- NRIM N/A
- VNDA N/A
- Industry
- NRIM Savings Institutions
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- NRIM Finance
- VNDA Health Care
- Exchange
- NRIM Nasdaq
- VNDA Nasdaq
- Market Cap
- NRIM 369.8M
- VNDA 270.2M
- IPO Year
- NRIM N/A
- VNDA 2006
- Fundamental
- Price
- NRIM $69.40
- VNDA $4.73
- Analyst Decision
- NRIM
- VNDA Buy
- Analyst Count
- NRIM 0
- VNDA 1
- Target Price
- NRIM N/A
- VNDA $13.00
- AVG Volume (30 Days)
- NRIM 23.6K
- VNDA 641.3K
- Earning Date
- NRIM 10-28-2024
- VNDA 11-06-2024
- Dividend Yield
- NRIM 3.63%
- VNDA N/A
- EPS Growth
- NRIM 13.73
- VNDA N/A
- EPS
- NRIM 5.78
- VNDA N/A
- Revenue
- NRIM $136,386,000.00
- VNDA $182,022,000.00
- Revenue This Year
- NRIM N/A
- VNDA $6.70
- Revenue Next Year
- NRIM $3.03
- VNDA $51.03
- P/E Ratio
- NRIM $11.78
- VNDA N/A
- Revenue Growth
- NRIM 6.71
- VNDA N/A
- 52 Week Low
- NRIM $38.65
- VNDA $3.30
- 52 Week High
- NRIM $74.34
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- NRIM 50.80
- VNDA 48.57
- Support Level
- NRIM $68.06
- VNDA $4.68
- Resistance Level
- NRIM $73.14
- VNDA $4.98
- Average True Range (ATR)
- NRIM 1.54
- VNDA 0.18
- MACD
- NRIM -0.04
- VNDA 0.05
- Stochastic Oscillator
- NRIM 45.00
- VNDA 40.00
About NRIM Northrim BanCorp Inc
Northrim BanCorp Inc is a bank holding company. The company operates in two segments: Community Banking and Home Mortgage Lending. It generates maximum revenue from the Community Banking segment. It offers to spend and save products such as checking, savings, money market accounts, debit cards, cashback rewards, and credit cards. It also includes loans and credit lines, mortgage loans, investment, and plan products.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.